Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Clin Nutr ; 56(3): 599-603, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1323926

ABSTRACT

A dietary supplement of linoleic acid (LA) as soy phosphatidylcholine (PC) or as triglyceride on polymorphonuclear leukocyte (PMNL) functions, arachidonate (AA) concentrations, AA release, and leukotriene B4 (LTB4) generation was studied in normal adults. Study 1: Eight subjects were fed PC (27 g) or placebo for 3 d in a blinded crossover experiment with PMNL assays at baseline and 4, 7, and 14 d. Study 2: Subjects were fed equal quantities of LA as PC (18 g, n = 8), safflower (SF, n = 4), or soybean oil (SY, n = 4) with PMNL assays at baseline and 48 h. Study 1: PC increased PMNL phagocytosis and killing of Candida albicans twofold (P less than 0.001) and PMNL phospholipid AA content threefold (P less than 0.001); AA release after Candida albicans stimulation increased 5.3-fold, correlating with PMNL killing (r = 0.932) and phagocytosis (r = 0.872). Study 2: PC, but not SF or SY, produced changes similar to those of study 1. With PMNL exposure to calcium ionophore A23187 or N-formyl-methionyl-leucyl-phenylalanine, PC increased LTB4 generation. Phospholipid LA, in contrast to triglyceride LA, enhanced PMNL phospholipid AA, phagocytosis, and killing.


Subject(s)
Arachidonic Acid/metabolism , Neutrophils/drug effects , Phagocytosis/drug effects , Phosphatidylcholines/pharmacology , Safflower Oil , Soybean Oil , Adult , Calcimycin/pharmacology , Female , Humans , Leukotriene B4/metabolism , Linoleic Acid , Linoleic Acids/pharmacology , Male , Middle Aged , Neutrophils/metabolism , Neutrophils/physiology , Phosphatidylcholines/administration & dosage
3.
Crit Care Med ; 16(7): 727-8, 1988 Jul.
Article in English | MEDLINE | ID: mdl-3131069

ABSTRACT

Excessive rates of carbohydrate infusion during total parenteral nutrition (TPN) have been reported to cause hypercapnia leading to respiratory failure or inability to wean from a ventilator. This case history illustrates the hitherto unreported syndrome of cyclic hypercapnia resulting from high rates of carbohydrate infusion during peak TPN flow rates when TPN was provided in a cyclic fashion. The patient was given TPN daily over an 18 1/2-h period followed by 5 1/2 h without nutritional support. Elevated CO2 production, increased respiratory quotient, hypercapnia, and inability to wean from a ventilator occurred during peak cycle TPN flow rates. When the same carbohydrate load was infused continuously over a 24-h period, CO2 production, respiratory quotient and PaCO2 were reduced. The patient was then able to tolerate periods of unassisted ventilation.


Subject(s)
Hypercapnia/etiology , Parenteral Nutrition, Total/adverse effects , Dietary Carbohydrates/administration & dosage , Humans , Male , Middle Aged , Parenteral Nutrition, Total/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...